Does INSULIN GLARGINE Cause Investigation? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Investigation have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.0% of all adverse event reports for INSULIN GLARGINE.
28
Reports of Investigation with INSULIN GLARGINE
0.0%
of all INSULIN GLARGINE reports
0
Deaths
28
Hospitalizations
How Dangerous Is Investigation From INSULIN GLARGINE?
Of the 28 reports, 28 (100.0%) required hospitalization.
Is Investigation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Investigation?
ARANESP (403)
NEULASTA (371)
XGEVA (115)
FLUTICASONE\SALMETEROL (96)
DARBEPOETIN ALFA (86)
ADVAIR (77)
DENOSUMAB (65)
ADVAIR HFA (51)
ALBUTEROL (51)
VENTOLIN (47)
Which INSULIN GLARGINE Alternatives Have Lower Investigation Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO